ICD Code Z85.42
ICD code Z85.42 is used to indicate a personal history of malignant neoplasm of the other parts of the skin.
Boost patient experience and your bottom line by automating patient cost estimates, payer underpayment detection, and contract optimization in one place.
What is ICD diagnosis code Z85.42
ICD code Z85.42 is a personal history of malignant neoplasm of other parts of the skin.
When to use ICD code Z85.42
1. Documented personal history of malignant neoplasm of the other parts of the skin
2. Patient has completed treatment for skin cancer and is no longer undergoing active therapy
3. Follow-up care or surveillance is being provided to monitor for recurrence or complications
4. No current evidence of active skin cancer at the time of encounter
5. Encounter is related to past diagnosis of skin cancer, such as routine check-ups, counseling, or management of late effects
Billable CPT codes for ICD code Z85.42
Applicable CPT codes for ICD code Z85.42 may include:
- 99202–99215 (Office or other outpatient evaluation and management services)
- 99381–99397 (Preventive medicine services)
- 77067 (Screening mammography, bilateral)
- 77063 (Screening digital breast tomosynthesis, bilateral)
- 88141–88175 (Cytopathology, cervical or vaginal)
- 88305 (Pathology examination of tissue)
- 19301 (Partial mastectomy)
- 19303 (Mastectomy, simple, complete)
- 19120 (Excision of breast lesion)
- 19083–19086 (Breast biopsy, with imaging guidance)
- 99241–99245 (Office consultation for a new or established patient)
CPT code selection should be based on the specific clinical scenario and services rendered.
Are you being underpaid for encounters with Z85.42
See how MD Clarity’s RevFind software can read your contracts and automatically detect underpayments for CPT codes related to ICD code Z85.42. Schedule a demo today to ensure your organization is capturing every dollar it’s owed.
Get paid in full by bringing clarity to your revenue cycle
Related ICD Codes
Subscribe to the

Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox
